These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1518874)

  • 1. [Muscarinic receptor subtypes].
    Pharm Unserer Zeit; 1992 Jul; 21(4):151-2. PubMed ID: 1518874
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
    Baumgold J; Drobnick A
    Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
    J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
    Eglen RM
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor subtypes in the heart--how many and why?
    Myslivecek J; Trojan S
    Sb Lek; 2001; 102(3):361-7. PubMed ID: 12092121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor subtypes and smooth muscle function.
    Eglen RM; Hegde SS; Watson N
    Pharmacol Rev; 1996 Dec; 48(4):531-65. PubMed ID: 8981565
    [No Abstract]   [Full Text] [Related]  

  • 8. [Subtypes and neuronal localization of muscarinic receptors in rat cerebral hemispheres].
    Kosmachev AB; Podosinovikova NP; Solov'eva NE; Dolgo-Saburov VV
    Eksp Klin Farmakol; 2000; 63(5):7-9. PubMed ID: 11109515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
    Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
    Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ; Oliff HS; Griffin MT
    J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes.
    Nguyen VT; Chernyavsky AI; Arredondo J; Bercovich D; Orr-Urtreger A; Vetter DE; Wess J; Beaudet AL; Kitajima Y; Grando SA
    Exp Cell Res; 2004 Apr; 294(2):534-49. PubMed ID: 15023540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
    J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the muscarinic receptor and its subtypes in patients with chronic obstructive pulmonary disease].
    Shen N; Yao W; Zhu H
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):212-4. PubMed ID: 11802965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
    Contrera JG; Mcleskey SW; Holopainen I; Xu J; Wojcik WJ
    J Pharmacol Exp Ther; 1993 Apr; 265(1):433-40. PubMed ID: 8474025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
    Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
    Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptors in the ocular surface.
    Enríquez-de-Salamanca A; Calonge M
    Curr Opin Allergy Clin Immunol; 2006 Oct; 6(5):379-82. PubMed ID: 16954793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.
    Zhang HM; Chen SR; Pan HL
    J Neurophysiol; 2007 Jan; 97(1):102-9. PubMed ID: 17050831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor subtypes in the alimentary tract.
    Tobin G; Giglio D; Lundgren O
    J Physiol Pharmacol; 2009 Mar; 60(1):3-21. PubMed ID: 19439804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of cortical muscarinic receptor subtypes.
    Vogt BA
    Trends Pharmacol Sci; 1988 Feb; Suppl():49-53. PubMed ID: 3074537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.